Aldosterone and Insulin Resistance: Vicious Combination in Patients on Maintenance Hemodialysis

Area of Science:

• Nephrology
• Endocrinology
• Cardiology

Background:

• Insulin resistance is common in chronic kidney disease.
• Plasma aldosterone's role in insulin resistance was previously shown.
• The clinical impact in hemodialysis patients requires further investigation.

Purpose of the Study:

• To investigate the clinical impact of the aldosterone-insulin resistance relationship in hemodialysis patients.
• To assess the association between plasma aldosterone, insulin resistance, and cardiovascular complications.

Main Methods:

• Cross-sectional study of 128 hemodialysis patients.
• Multiple regression analysis to determine independent associations.
• Comparison of cardiovascular parameters based on aldosterone and HOMA-IR tertiles.

Main Results:

• Plasma aldosterone levels were independently associated with insulin resistance (HOMA-IR).
• The association was more pronounced in diabetic hemodialysis patients.
• Both aldosterone and HOMA-IR correlated with cardiac hypertrophy; higher levels of both were linked to more severe cardiac damage and reduced function.

Conclusions:

• Plasma aldosterone and insulin resistance are closely interrelated in hemodialysis patients.
• The combination of high aldosterone and insulin resistance is associated with significant cardiovascular tissue damage.
• These findings highlight potential therapeutic targets for managing cardiovascular risk in this population.